+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Non-Therapeutic Antibiotics for Food Animals Market - Global Forecast 2026-2032- Product Image
Non-Therapeutic Antibiotics for Food Animals Market - Global Forecast 2026-2032- Product Image
Sale

Non-Therapeutic Antibiotics for Food Animals Market - Global Forecast 2026-2032

  • Report

  • 185 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 5337508
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Non-Therapeutic Antibiotics for Food Animals Market is projected to reach USD 6.24 Billion in 2026. It is expected to continue growing at a CAGR of 7.27%, reaching USD 9.55 Billion by 2032.

Non-therapeutic antibiotics for food animals include antimicrobial use for growth promotion, feed efficiency, and routine disease prevention rather than treatment of a diagnosed illness. This category remains a high-scrutiny segment of animal health because it sits at the intersection of food security, livestock productivity, antimicrobial resistance, and global trade compliance.

Verified public-health guidance from WHO, FAO, and WOAH continues to prioritize responsible antimicrobial use in livestock under the One Health framework. As regulators restrict medically important antibiotics for production purposes, industry value is shifting from volume-led antibiotic consumption toward veterinary oversight, diagnostics, vaccination, biosecurity, improved nutrition, and antibiotic alternatives.

Transformative Shifts in the Market Landscape

The most important structural shift is regulatory. The European Union banned antibiotic growth promoters in 2006, the United States implemented the Veterinary Feed Directive in 2017, and FDA Guidance for Industry 263 brought remaining over-the-counter medically important animal antibiotics under veterinary prescription status in 2023. Canada, China, and several other major producers have also tightened controls on growth-promotion claims, medicated feed additives, and veterinary authorization.

Commercial strategies are therefore moving away from routine antibiotic inputs and toward integrated herd and flock health management. Producers are investing in vaccination, nutrition, probiotics, prebiotics, enzymes, improved housing, manure management, and disease surveillance to protect productivity while meeting retailer, exporter, and consumer expectations for antibiotic stewardship.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is accelerating the transition from routine non-therapeutic antibiotic use to precision animal health management. AI-enabled sensors, computer vision, acoustic monitoring, thermal imaging, and predictive analytics can detect changes in feed intake, mobility, body temperature, coughing, behavior, or mortality patterns before disease spreads across a herd or flock.

The cumulative impact is a more data-driven operating model for livestock production. AI supports targeted veterinary intervention, antimicrobial use benchmarking, resistance surveillance, welfare monitoring, and audit-ready compliance documentation. Adoption depends on data quality, farm connectivity, validated algorithms, cybersecurity, and integration with veterinary workflows, but the direction is clear: AI reduces reliance on blanket prevention and strengthens evidence-based antibiotic stewardship.

Key Regional Insights

Asia-Pacific is a major livestock-production growth arena, led by China, India, Southeast Asia, Japan, South Korea, and Australia, but stewardship intensity varies by country. China has implemented major restrictions, including the prohibition of colistin as a growth promoter and tighter rules on medicated feed additives, while Australia and Japan maintain highly structured veterinary oversight and food-safety controls. India and ASEAN economies are increasingly focused on residue control, farm biosecurity, and surveillance as animal protein demand rises.

North America is shaped by mature regulation and transparent sales reporting, with U.S. FDA summaries showing substantial declines in medically important antimicrobial sales for food-producing animals compared with the 2015 peak. Europe remains the global benchmark for reduction policy, supported by ESVAC reporting and the EU Farm to Fork target to cut antimicrobial sales for farmed animals and aquaculture by 50% by 2030 versus 2018. Latin America is advancing stewardship through export-driven compliance, particularly in poultry, beef, and pork supply chains, while the Middle East is strengthening biosecurity and veterinary controls in intensive poultry and dairy systems. Africa faces higher variability in veterinary access, diagnostics, and enforcement, making capacity building, surveillance, and responsible-use education central to reducing non-therapeutic antibiotic dependence.

Key Group Insights

ASEAN markets are balancing fast-rising animal protein demand with improving veterinary governance, making the region important for antibiotic alternatives, feed additives, vaccination programs, and surveillance platforms. GCC countries rely heavily on food imports but are investing in domestic poultry, dairy, aquaculture, and biosecurity systems, creating demand for compliant animal-health protocols and residue-control programs.

The European Union leads through legally binding restrictions, harmonized monitoring, and measurable antimicrobial-reduction targets. BRICS countries represent major livestock output and policy diversity, with China, India, Brazil, Russia, and South Africa influencing global production practices, feed systems, and export requirements. G7 markets are driving retailer standards, traceability, AMR policy, and transparent antimicrobial-use reporting, while NATO economies overlap with many high-compliance veterinary medicine markets where food-system resilience, biosecurity, and supply-chain assurance are strategic priorities.

Key Country Insights

The United States, Canada, and Mexico are defined by veterinary oversight, integrated meat supply chains, and export-sensitive compliance, with the United States emphasizing prescription control, medicated feed authorization, and annual antimicrobial sales reporting. Brazil remains central to global beef and poultry trade, making antimicrobial stewardship increasingly relevant to residue compliance, market access, and buyer standards. The United Kingdom, Germany, France, Italy, and Spain operate under strict European-aligned frameworks, with Germany and France historically influential in antimicrobial reduction programs and Spain implementing national action plans that have reported major reductions in veterinary antimicrobial consumption.

China and India are pivotal because of livestock scale, disease pressure, and evolving regulation; China has moved aggressively on feed-additive restrictions, while India’s priorities include residue monitoring, poultry and dairy health management, and expanded veterinary capacity. Japan, South Korea, and Australia combine strong food-safety systems with high consumer expectations and structured veterinary controls. Russia remains important in poultry and pork self-sufficiency, while country-specific enforcement, veterinary capacity, antimicrobial-use reporting, and on-farm biosecurity continue to shape adoption of non-antibiotic prevention strategies across all major producing nations.

Actionable Recommendations for Industry Leaders

Industry leaders should treat non-therapeutic antibiotic reduction as a competitiveness strategy rather than a compliance burden. Priority actions include implementing veterinary-led antimicrobial stewardship plans, benchmarking usage by species and production stage, improving disease-risk mapping, and replacing routine prevention with vaccination, diagnostics, biosecurity, welfare-focused housing, and nutrition-based health programs.

Companies should also strengthen supplier audits, digital traceability, residue-control systems, and resistance-risk reporting to meet retailer and export-market expectations. Investment in AI-enabled disease detection, farm data interoperability, workforce training, and validated antibiotic alternatives can protect productivity while reducing regulatory, reputational, and market-access risk.

Research Methodology

The research applies a triangulated methodology that integrates public regulatory databases, veterinary antimicrobial sales reports, national policy documents, peer-reviewed literature, trade data, food-safety guidance, and expert validation. Key reference sources include WHO, FAO, WOAH, FDA, EMA ESVAC, EFSA, ECDC, Health Canada, national agriculture ministries, and veterinary authorities.

The analysis evaluates regulatory direction, livestock production patterns, antimicrobial-use reporting, residue-control requirements, supply-chain standards, retailer commitments, and adoption of antibiotic alternatives. Findings are cross-checked across primary and secondary sources to ensure accuracy, market relevance, and consistency with verified public data while avoiding unsupported assumptions, market sizing, or forecasting.

Conclusion

The non-therapeutic antibiotics for food animals landscape is undergoing a long-term structural reset. Growth-promotion use and routine preventive administration of medically important antibiotics are increasingly constrained by regulation, consumer expectations, retailer standards, food-safety requirements, and antimicrobial-resistance policy.

Future value will concentrate in systems that maintain animal health without routine antibiotic dependence. Producers, animal-health suppliers, feed manufacturers, integrators, and retailers that combine stewardship, diagnostics, vaccination, AI-enabled monitoring, biosecurity, and transparent reporting will be best positioned for compliant and resilient growth.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Non-Therapeutic Antibiotics for Food Animals Market, by Animal Type
7.1. Introduction
7.2. Aquaculture
7.3. Cattle
7.4. Poultry
7.5. Swine
8. Non-Therapeutic Antibiotics for Food Animals Market, by Product Type
8.1. Introduction
8.2. Aminoglycosides
8.2.1. Gentamicin
8.2.2. Neomycin
8.2.3. Streptomycin
8.3. Macrolides
8.3.1. Erythromycin
8.3.2. Tilmicosin
8.3.3. Tylosin
8.4. Penicillins
8.4.1. Amoxicillin
8.4.2. Ampicillin
8.4.3. Penicillin G
8.5. Sulfonamides
8.5.1. Sulfadiazine
8.5.2. Sulfamethazine
8.5.3. Sulfamethoxazole
8.6. Tetracyclines
8.6.1. Chlortetracycline
8.6.2. Oxytetracycline
8.6.3. Tetracycline
9. Non-Therapeutic Antibiotics for Food Animals Market, by Formulation
9.1. Introduction
9.2. Feed Additives
9.3. Oral Suspensions
9.4. Water Soluble Powders
10. Non-Therapeutic Antibiotics for Food Animals Market, by Application Mode
10.1. Introduction
10.2. In Feed
10.3. In Water
11. Non-Therapeutic Antibiotics for Food Animals Market, by End Use
11.1. Introduction
11.2. Growth Promotion
11.3. Prophylaxis
12. Non-Therapeutic Antibiotics for Food Animals Market, by Sales Channel
12.1. Introduction
12.2. Feed Mills
12.3. Retail Pharmacies
12.4. Veterinary Distributors
13. Non-Therapeutic Antibiotics for Food Animals Market, by Region
13.1. Asia-Pacific
13.2. North America
13.3. Latin America
13.4. Europe
13.5. Middle East
13.6. Africa
14. Non-Therapeutic Antibiotics for Food Animals Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Non-Therapeutic Antibiotics for Food Animals Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. FPNV Positioning Matrix, 2025
16.3. Market Concentration Analysis, 2025
16.3.1. Concentration Ratio (CR)
16.3.2. Herfindahl Hirschman Index (HHI)
16.4. Recent Developments & Impact Analysis, 2025
16.5. Product Portfolio Analysis, 2025
16.6. Benchmarking Analysis, 2025
17. Company Profiles
17.1. AdvaCare Pharma
17.2. Ashish Life Science Pvt. Ltd.
17.3. Bimeda Holdings Limited
17.4. Boehringer Ingelheim International GmbH
17.5. Ceva Santé Animale S.A.
17.6. Chanelle Pharma
17.7. China Animal Husbandry Industry Co., Ltd.
17.8. Dechra Pharmaceuticals PLC
17.9. ECO Animal Health Group Plc
17.10. Elanco Animal Health Incorporated
17.11. Endovac Animal Health
17.12. Hester Biosciences Ltd.
17.13. HIPRA, S.A.
17.14. Huvepharma S.A.
17.15. Indian Immunologicals Ltd.
17.16. Inovet Group
17.17. Intas Pharmaceuticals Ltd.
17.18. Kyoritsu Seiyaku Corporation
17.19. Meiji Holdings Co., Ltd.
17.20. Merck & Co., Inc.
17.21. Norbrook Laboratories Limited
17.22. Ouro Fino Saúde Animal
17.23. Phibro Animal Health Corporation
17.24. SeQuent Scientific Ltd.
17.25. Vetoquinol S.A.
17.26. Vetsfarma Ltd.
17.27. Virbac S.A.
17.28. Zoetis Inc.
List of Figures
FIGURE 1. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2025 VS 2032 (%)
FIGURE 11. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2025 VS 2032 (%)
FIGURE 13. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2025 VS 2032 (%)
FIGURE 15. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2025 VS 2032 (%)
FIGURE 17. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 21. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 23. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 25. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL AQUACULTURE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL AQUACULTURE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL AQUACULTURE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL CATTLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL CATTLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL CATTLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL POULTRY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL POULTRY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL POULTRY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL SWINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL SWINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL SWINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL GENTAMICIN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL GENTAMICIN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL GENTAMICIN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL NEOMYCIN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL NEOMYCIN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL NEOMYCIN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL STREPTOMYCIN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL STREPTOMYCIN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL STREPTOMYCIN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL MACROLIDES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL MACROLIDES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL MACROLIDES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL ERYTHROMYCIN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL ERYTHROMYCIN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL ERYTHROMYCIN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL TILMICOSIN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL TILMICOSIN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL TILMICOSIN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL TYLOSIN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL TYLOSIN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL TYLOSIN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL PENICILLINS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL PENICILLINS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL PENICILLINS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL AMOXICILLIN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL AMOXICILLIN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL AMOXICILLIN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL AMPICILLIN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL AMPICILLIN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL AMPICILLIN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL PENICILLIN G MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL PENICILLIN G MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL PENICILLIN G MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL SULFONAMIDES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL SULFONAMIDES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL SULFONAMIDES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL SULFADIAZINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL SULFADIAZINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL SULFADIAZINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL SULFAMETHAZINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL SULFAMETHAZINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL SULFAMETHAZINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL SULFAMETHOXAZOLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL SULFAMETHOXAZOLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL SULFAMETHOXAZOLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL TETRACYCLINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL TETRACYCLINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL TETRACYCLINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL CHLORTETRACYCLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL CHLORTETRACYCLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL CHLORTETRACYCLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL OXYTETRACYCLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL OXYTETRACYCLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL OXYTETRACYCLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL TETRACYCLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL TETRACYCLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL TETRACYCLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL FEED ADDITIVES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL FEED ADDITIVES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL FEED ADDITIVES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL ORAL SUSPENSIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL ORAL SUSPENSIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL ORAL SUSPENSIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL WATER SOLUBLE POWDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL WATER SOLUBLE POWDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL WATER SOLUBLE POWDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL IN FEED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL IN FEED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL IN FEED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL IN WATER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL IN WATER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL IN WATER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL GROWTH PROMOTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL GROWTH PROMOTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL GROWTH PROMOTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL PROPHYLAXIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL PROPHYLAXIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL PROPHYLAXIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL FEED MILLS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL FEED MILLS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL FEED MILLS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL VETERINARY DISTRIBUTORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL VETERINARY DISTRIBUTORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL VETERINARY DISTRIBUTORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 112. ASIA-PACIFIC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 113. ASIA-PACIFIC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 114. ASIA-PACIFIC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 115. ASIA-PACIFIC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2017-2032 (USD MILLION)
TABLE 116. ASIA-PACIFIC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2017-2032 (USD MILLION)
TABLE 117. ASIA-PACIFIC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2017-2032 (USD MILLION)
TABLE 118. ASIA-PACIFIC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2017-2032 (USD MILLION)
TABLE 119. ASIA-PACIFIC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2017-2032 (USD MILLION)
TABLE 120. ASIA-PACIFIC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 121. ASIA-PACIFIC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2017-2032 (USD MILLION)
TABLE 122. ASIA-PACIFIC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2017-2032 (USD MILLION)
TABLE 123. ASIA-PACIFIC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 124. NORTH AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 125. NORTH AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 126. NORTH AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 127. NORTH AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2017-2032 (USD MILLION)
TABLE 128. NORTH AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2017-2032 (USD MILLION)
TABLE 129. NORTH AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2017-2032 (USD MILLION)
TABLE 130. NORTH AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2017-2032 (USD MILLION)
TABLE 131. NORTH AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2017-2032 (USD MILLION)
TABLE 132. NORTH AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 133. NORTH AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2017-2032 (USD MILLION)
TABLE 134. NORTH AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2017-2032 (USD MILLION)
TABLE 135. NORTH AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 136. LATIN AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 137. LATIN AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 138. LATIN AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 139. LATIN AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2017-2032 (USD MILLION)
TABLE 140. LATIN AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2017-2032 (USD MILLION)
TABLE 141. LATIN AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2017-2032 (USD MILLION)
TABLE 142. LATIN AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2017-2032 (USD MILLION)
TABLE 143. LATIN AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2017-2032 (USD MILLION)
TABLE 144. LATIN AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 145. LATIN AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2017-2032 (USD MILLION)
TABLE 146. LATIN AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2017-2032 (USD MILLION)
TABLE 147. LATIN AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 148. EUROPE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 149. EUROPE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 150. EUROPE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 151. EUROPE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2017-2032 (USD MILLION)
TABLE 152. EUROPE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2017-2032 (USD MILLION)
TABLE 153. EUROPE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2017-2032 (USD MILLION)
TABLE 154. EUROPE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2017-2032 (USD MILLION)
TABLE 155. EUROPE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2017-2032 (USD MILLION)
TABLE 156. EUROPE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 157. EUROPE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2017-2032 (USD MILLION)
TABLE 158. EUROPE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2017-2032 (USD MILLION)
TABLE 159. EUROPE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 160. MIDDLE EAST NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 161. MIDDLE EAST NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 162. MIDDLE EAST NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 163. MIDDLE EAST NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2017-2032 (USD MILLION)
TABLE 164. MIDDLE EAST NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2017-2032 (USD MILLION)
TABLE 165. MIDDLE EAST NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2017-2032 (USD MILLION)
TABLE 166. MIDDLE EAST NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2017-2032 (USD MILLION)
TABLE 167. MIDDLE EAST NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2017-2032 (USD MILLION)
TABLE 168. MIDDLE EAST NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 169. MIDDLE EAST NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2017-2032 (USD MILLION)
TABLE 170. MIDDLE EAST NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2017-2032 (USD MILLION)
TABLE 171. MIDDLE EAST NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 172. AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 173. AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 174. AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 175. AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2017-2032 (USD MILLION)
TABLE 176. AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2017-2032 (USD MILLION)
TABLE 177. AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2017-2032 (USD MILLION)
TABLE 178. AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2017-2032 (USD MILLION)
TABLE 179. AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2017-2032 (USD MILLION)
TABLE 180. AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 181. AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2017-2032 (USD MILLION)
TABLE 182. AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2017-2032 (USD MILLION)
TABLE 183. AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 184. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 185. ASEAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 186. ASEAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 187. ASEAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 188. ASEAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2017-2032 (USD MILLION)
TABLE 189. ASEAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2017-2032 (USD MILLION)
TABLE 190. ASEAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2017-2032 (USD MILLION)
TABLE 191. ASEAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2017-2032 (USD MILLION)
TABLE 192. ASEAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2017-2032 (USD MILLION)
TABLE 193. ASEAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 194. ASEAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2017-2032 (USD MILLION)
TABLE 195. ASEAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2017-2032 (USD MILLION)
TABLE 196. ASEAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 197. GCC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 198. GCC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 199. GCC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 200. GCC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2017-2032 (USD MILLION)
TABLE 201. GCC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2017-2032 (USD MILLION)
TABLE 202. GCC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2017-2032 (USD MILLION)
TABLE 203. GCC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2017-2032 (USD MILLION)
TABLE 204. GCC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2017-2032 (USD MILLION)
TABLE 205. GCC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 206. GCC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2017-2032 (USD MILLION)
TABLE 207. GCC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2017-2032 (USD MILLION)
TABLE 208. GCC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 209. EUROPEAN UNION NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 210. EUROPEAN UNION NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 211. EUROPEAN UNION NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 212. EUROPEAN UNION NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2017-2032 (USD MILLION)
TABLE 213. EUROPEAN UNION NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2017-2032 (USD MILLION)
TABLE 214. EUROPEAN UNION NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2017-2032 (USD MILLION)
TABLE 215. EUROPEAN UNION NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2017-2032 (USD MILLION)
TABLE 216. EUROPEAN UNION NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2017-2032 (USD MILLION)
TABLE 217. EUROPEAN UNION NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 218. EUROPEAN UNION NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2017-2032 (USD MILLION)
TABLE 219. EUROPEAN UNION NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2017-2032 (USD MILLION)
TABLE 220. EUROPEAN UNION NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 221. BRICS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 222. BRICS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 223. BRICS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 224. BRICS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2017-2032 (USD MILLION)
TABLE 225. BRICS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2017-2032 (USD MILLION)
TABLE 226. BRICS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2017-2032 (USD MILLION)
TABLE 227. BRICS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2017-2032 (USD MILLION)
TABLE 228. BRICS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2017-2032 (USD MILLION)
TABLE 229. BRICS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 230. BRICS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2017-2032 (USD MILLION)
TABLE 231. BRICS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2017-2032 (USD MILLION)
TABLE 232. BRICS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 233. G7 NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 234. G7 NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 235. G7 NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 236. G7 NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2017-2032 (USD MILLION)
TABLE 237. G7 NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2017-2032 (USD MILLION)
TABLE 238. G7 NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2017-2032 (USD MILLION)
TABLE 239. G7 NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2017-2032 (USD MILLION)
TABLE 240. G7 NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2017-2032 (USD MILLION)
TABLE 241. G7 NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 242. G7 NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2017-2032 (USD MILLION)
TABLE 243. G7 NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2017-2032 (USD MILLION)
TABLE 244. G7 NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 245. NATO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 246. NATO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 247. NATO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 248. NATO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2017-2032 (USD MILLION)
TABLE 249. NATO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2017-2032 (USD MILLION)
TABLE 250. NATO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2017-2032 (USD MILLION)
TABLE 251. NATO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2017-2032 (USD MILLION)
TABLE 252. NATO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2017-2032 (USD MILLION)
TABLE 253. NATO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 254. NATO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2017-2032 (USD MILLION)
TABLE 255. NATO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2017-2032 (USD MILLION)
TABLE 256. NATO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 257. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 258. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 259. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 260. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 261. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2017-2032 (USD MILLION)
TABLE 262. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2017-2032 (USD MILLION)
TABLE 263. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2017-2032 (USD MILLION)
TABLE 264. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2017-2032 (USD MILLION)
TABLE 265. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2017-2032 (USD MILLION)
TABLE 266. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 267. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2017-2032 (USD MILLION)
TABLE 268. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2017-2032 (USD MILLION)
TABLE 269. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 270. CANADA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 271. CANADA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 272. CANADA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 273. CANADA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2017-2032 (USD MILLION)
TABLE 274. CANADA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2017-2032 (USD MILLION)
TABLE 275. CANADA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2017-2032 (USD MILLION)
TABLE 276. CANADA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2017-2032 (USD MILLION)
TABLE 277. CANADA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2017-2032 (USD MILLION)
TABLE 278. CANADA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 279. CANADA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2017-2032 (USD MILLION)
TABLE 280. CANADA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2017-2032 (USD MILLION)
TABLE 281. CANADA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 282. MEXICO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 283. MEXICO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 284. MEXICO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 285. MEXICO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2017-2032 (USD MILLION)
TABLE 286. MEXICO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2017-2032 (USD MILLION)
TABLE 287. MEXICO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2017-2032 (USD MILLION)
TABLE 288. MEXICO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2017-2032 (USD MILLION)
TABLE 289. MEXICO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2017-2032 (USD MILLION)
TABLE 290. MEXICO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 291. MEXICO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2017-2032 (USD MILLION)
TABLE 292. MEXICO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2017-2032 (USD MILLION)
TABLE 293. MEXICO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 294. BRAZIL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 295. BRAZIL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 296. BRAZIL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 297. BRAZIL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2017-2032 (USD MILLION)
TABLE 298. BRAZIL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2017-2032 (USD MILLION)
TABLE 299. BRAZIL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2017-2032 (USD MILLION)
TABLE 300. BRAZIL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2017-2032 (USD MILLION)
TABLE 301. BRAZIL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2017-2032 (USD MILLION)
TABLE 302. BRAZIL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 303. BRAZIL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2017-2032 (USD MILLION)
TABLE 304. BRAZIL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2017-2032 (USD MILLION)
TABLE 305. BRAZIL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 306. UNITED KINGDOM NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 307. UNITED KINGDOM NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 308. UNITED KINGDOM NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 309. UNITED KINGDOM NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2017-2032 (USD MILLION)
TABLE 310. UNITED KINGDOM NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2017-2032 (USD MILLION)
TABLE 311. UNITED KINGDOM NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2017-2032 (USD MILLION)
TABLE 312. UNITED KINGDOM NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2017-2032 (USD MILLION)
TABLE 313. UNITED KINGDOM NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS M

Companies Mentioned

  • AdvaCare Pharma
  • Ashish Life Science Pvt. Ltd.
  • Bimeda Holdings Limited
  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale S.A.
  • Chanelle Pharma
  • China Animal Husbandry Industry Co., Ltd.
  • Dechra Pharmaceuticals PLC
  • ECO Animal Health Group Plc
  • Elanco Animal Health Incorporated
  • Endovac Animal Health
  • Hester Biosciences Ltd.
  • HIPRA, S.A.
  • Huvepharma S.A.
  • Indian Immunologicals Ltd.
  • Inovet Group
  • Intas Pharmaceuticals Ltd.
  • Kyoritsu Seiyaku Corporation
  • Meiji Holdings Co., Ltd.
  • Merck & Co., Inc.
  • Norbrook Laboratories Limited
  • Ouro Fino Saúde Animal
  • Phibro Animal Health Corporation
  • SeQuent Scientific Ltd.
  • Vetoquinol S.A.
  • Vetsfarma Ltd.
  • Virbac S.A.
  • Zoetis Inc.

Table Information

Report AttributeDetails
No. of Pages185
PublishedSeptember 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 6.24 Billion
Forecasted Market Value ( USD ) by 2032 $ 9.55 Billion
Compound Annual Growth Rate7.2%
Regions CoveredGlobal
No. of Companies Mentioned28

Related Topics

Related Reports

2025 Global Forecast for Non-Therapeutic Antibiotics For Food Animals Market (2026-2031): High Tech Outlook Report - Product Image

2025 Global Forecast for Non-Therapeutic Antibiotics For Food Animals Market (2026-2031): High Tech Outlook Report

  • Report
  • 132 Pages
  • Global
From
Animal Antibiotics & Antimicrobials Market - Global Forecast 2026-2032 - Product Image

Animal Antibiotics & Antimicrobials Market - Global Forecast 2026-2032

  • Report
  • 180 Pages
  • Global
From
Animal Pharmaceuticals Market - Global Forecast 2026-2032 - Product Image

Animal Pharmaceuticals Market - Global Forecast 2026-2032

  • Report
  • 197 Pages
  • Global
From
Animal Antibiotics and Antimicrobials - Global Strategic Business Report - Product Image

Animal Antibiotics and Antimicrobials - Global Strategic Business Report

  • Report
  • 282 Pages
  • Global
From
Feed Antibiotics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Feed Antibiotics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 120 Pages
  • Global
From

About the Non Therapeutic Animal Antibiotics Market

Non-therapeutic animal antibiotics are a type of animal feedstuff used to promote growth and prevent disease in livestock. They are typically added to feed in low doses to prevent the spread of disease and to increase the efficiency of feed conversion. Non-therapeutic antibiotics are used to supplement the natural immunity of animals, and to reduce the risk of infection from bacteria, viruses, and parasites. They are also used to reduce the cost of production and to improve the quality of meat and milk products. Non-therapeutic animal antibiotics are regulated by the Food and Drug Administration (FDA) and the Environmental Protection Agency (EPA). The FDA has established guidelines for the use of these antibiotics in animal feedstuffs, and the EPA has established limits on the amount of antibiotics that can be used in animal feed. Some of the major companies in the non-therapeutic animal antibiotics market include Bayer AG, Elanco Animal Health, Merck & Co., Inc., Zoetis, Inc., and Novartis AG. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.